LIPO
LIPELLA PHARMACEUTICALS INC.
Key Financials
Net Income
$-5016264
↓ 8.6%
Revenue
$536357
↑ 19.3%
Operating Income
$-5080542
↓ 7.0%
Total Assets
$2.7M
↓ 25.3%
Total Liabilities
$754417.00
↑ 74.3%
Shareholders' Equity
$1.9M
↓ 39.0%
Cash & Equivalents
$2.2M
↓ 33.7%
EPS (Diluted)
$-4.79
↓ 522.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 3/31/2026 | View on SEC |
| 8-K | 2/4/2026 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| 8-K | 10/21/2025 | View on SEC |
| 8-K | 10/9/2025 | View on SEC |
| 25-NSE | 10/6/2025 | View on SEC |
| 8-K | 9/18/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 8-K | 6/25/2025 | View on SEC |
| 8-K | 6/20/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LIPO |
| Company Name | LIPELLA PHARMACEUTICALS INC. |
| CIK | 1347242 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 412-901-0315 |